{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:07:36Z","timestamp":1786489656276,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH"},{"name":"NIH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reactive oxygen species (ROS) contribute to myocardial death during ischemia-reperfusion (I\/R) injury, but detailed knowledge of molecular pathways connecting ROS to cardiac injury is lacking. Activation of the Ca<jats:sup>2+<\/jats:sup>\/calmodulin-dependent protein kinase II (CaMKII\u03b4) is implicated in myocardial death, and CaMKII can be activated by ROS (ox-CaMKII) through oxidation of regulatory domain methionines (Met281\/282). We examined I\/R injury in mice where CaMKII\u03b4 was made resistant to ROS activation by knock-in replacement of regulatory domain methionines with valines (MMVV). We found reduced myocardial death, and improved left ventricular function 24\u2009hours after I\/R injury in MMVV <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> compared to WT controls. Loss of ATP sensitive K<jats:sup>+<\/jats:sup> channel (KATP) current contributes to I\/R injury, and CaMKII promotes sequestration of KATP from myocardial cell membranes. KATP current density was significantly reduced by H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> in WT ventricular myocytes, but not in MMVV, showing ox-CaMKII decreases KATP availability. Taken together, these findings support a view that ox-CaMKII and KATP are components of a signaling axis promoting I\/R injury by ROS.<\/jats:p>","DOI":"10.1038\/s41598-019-45743-6","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T10:02:56Z","timestamp":1561543376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKII\u03b4 oxidation"],"prefix":"10.1038","volume":"9","author":[{"given":"Yuejin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"45743_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra1112570","volume":"366","author":"EG Nabel","year":"2012","unstructured":"Nabel, E. G. & Braunwald, E. A. Tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 366, 54\u201363 (2012).","journal-title":"N. Engl. J. Med."},{"key":"45743_CR2","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ib\u00e1\u00f1ez","year":"2015","unstructured":"Ib\u00e1\u00f1ez, B., Heusch, G., Ovize, M. & Van de Werf, F. Evolving therapies for myocardial ischemia\/reperfusion injury. J. Am. Coll. Cardiol. 65, 1454\u20131471 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"45743_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrcardio.2014.137","volume":"11","author":"V Fuster","year":"2014","unstructured":"Fuster, V. Top 10 cardiovascular therapies and interventions for the next decade. Nat. Rev. Cardiol. 11, 671\u2013683 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"45743_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121\u201335 (2007).","journal-title":"N. Engl. J. Med."},{"key":"45743_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 515, 431\u2013435 (2014).","journal-title":"Nature."},{"key":"45743_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2013.04.010","volume":"66","author":"MP Murphy","year":"2014","unstructured":"Murphy, M. P. Antioxidants as therapies: can we improve on nature? Free Radic. Biol. Med. 66, 20\u20133 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"45743_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"JR Erickson","year":"2008","unstructured":"Erickson, J. R. et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 133, 462\u2013474 (2008).","journal-title":"Cell."},{"key":"45743_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.yjmcc.2008.02.128","volume":"44","author":"J Palomeque","year":"2008","unstructured":"Palomeque, J. et al. CaMKII mediates angiotensin II-induced cardiomyocytes apoptosis: role of Ca2+, ROS and p38 MAPK. J. Mol. Cell Cardiol. 44, 764\u2013765 (2008).","journal-title":"J. Mol. Cell Cardiol."},{"key":"45743_CR9","doi-asserted-by":"publisher","first-page":"44573","DOI":"10.1074\/jbc.M404175200","volume":"279","author":"CJ Howe","year":"2004","unstructured":"Howe, C. J., Lahair, M. M., McCubrey, J. A. & Franklin, R. A. Redox regulation of the calcium\/calmodulin-dependent protein kinases. J. Biol. Chem. 279, 44573\u201344581 (2004).","journal-title":"J. Biol. Chem."},{"key":"45743_CR10","doi-asserted-by":"publisher","first-page":"e1000426","DOI":"10.1371\/journal.pbio.1000426","volume":"8","author":"P Rellos","year":"2010","unstructured":"Rellos, P. et al. Structure of the CaMKII\u03b4\/Calmodulin Complex Reveals the Molecular Mechanism of CaMKII Kinase Activation. PLoS Biol. 8, e1000426 (2010).","journal-title":"PLoS Biol."},{"key":"45743_CR11","doi-asserted-by":"publisher","first-page":"H1177","DOI":"10.1152\/ajpheart.00007.2015","volume":"308","author":"A Mattiazzi","year":"2015","unstructured":"Mattiazzi, A. et al. Chasing cardiac physiology and pathology down the CaMKII cascade. Am. J. Physiol. Heart Circ. Physiol. 308, H1177\u201391 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"45743_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/1440-1681.12301","volume":"41","author":"JR Bell","year":"2014","unstructured":"Bell, J. R., Erickson, J. R. & Delbridge, L. M. Ca(2+)\/calmodulin dependent kinase II: a critical mediator in determining reperfusion outcomes in the heart? Clin. Exp. Pharmacol. Physiol. 41, 940\u20136 (2014).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"45743_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1172\/JCI65268","volume":"123","author":"M Luo","year":"2013","unstructured":"Luo, M. et al. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J. Clin. Invest. 123, 1262\u20131274 (2013).","journal-title":"J. Clin. Invest."},{"key":"45743_CR14","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.113.003313","volume":"128","author":"A Purohit","year":"2013","unstructured":"Purohit, A. et al. Oxidized Ca(2+)\/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation. 128, 1748\u201357 (2013).","journal-title":"Circulation."},{"key":"45743_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1152\/physrev.00003.2015","volume":"96","author":"MN Foster","year":"2016","unstructured":"Foster, M. N. & Coetzee, W. A. KATP Channels in the Cardiovascular System. Physiol. Rev. 96, 177\u2013252 (2016).","journal-title":"Physiol. Rev."},{"key":"45743_CR16","doi-asserted-by":"publisher","first-page":"H1508","DOI":"10.1152\/ajpheart.00540.2013","volume":"305","author":"NM Storey","year":"2013","unstructured":"Storey, N. M., Stratton, R. C., Rainbow, R. D., Standen, N. B. & Lodwick, D. Kir6.2 limits Ca(2+) overload and mitochondrial oscillations of ventricular myocytes in response to metabolic stress. Am. J. Physiol. Heart Circ. Physiol. 305, H1508\u201318 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"45743_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4161\/chan.5449","volume":"1","author":"J Li","year":"2007","unstructured":"Li, J. et al. Calmodulin kinase II inhibition enhances ischemic preconditioning by augmenting ATP-sensitive K+ current. Channels (Austin). 1, 387\u201394 (2007).","journal-title":"Channels (Austin)."},{"key":"45743_CR18","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1074\/jbc.M112.429548","volume":"288","author":"A Sierra","year":"2013","unstructured":"Sierra, A. et al. Regulation of cardiac ATP-sensitive potassium channel surface expression by calcium\/calmodulin-dependent protein kinase II. J. Biol. Chem. 288, 1568\u201381 (2013).","journal-title":"J. Biol. Chem."},{"key":"45743_CR19","doi-asserted-by":"publisher","first-page":"17576","DOI":"10.1073\/pnas.1314195110","volume":"110","author":"CF Kline","year":"2013","unstructured":"Kline, C. F. et al. IV-Spectrin and CaMKII facilitate Kir6.2 regulation in pancreatic beta cells. Proc. Natl. Acad. Sci. USA 110, 17576\u201381 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"45743_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cardiores.2006.12.003","volume":"73","author":"M Vila-Petroff","year":"2007","unstructured":"Vila-Petroff, M. et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc. Res. 73, 689\u201398 (2007).","journal-title":"Cardiovasc. Res."},{"key":"45743_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.yjmcc.2014.06.004","volume":"74","author":"MN Di Carlo","year":"2014","unstructured":"Di Carlo, M. N. et al. CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia\/reperfusion injury. J. Mol. Cell Cardiol. 74, 274\u201383 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"45743_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.yjmcc.2017.01.002","volume":"103","author":"CB Gray","year":"2017","unstructured":"Gray, C. B. et al. CaMKII\u03b4 subtypes differentially regulate infarct formation following ex vivo myocardial ischemia\/reperfusion through NF-\u03baB and TNF-\u03b1. J. Mol. Cell Cardiol. 103, 48\u201355 (2017).","journal-title":"J. Mol. Cell Cardiol."},{"key":"45743_CR23","doi-asserted-by":"publisher","first-page":"e90139","DOI":"10.1172\/jci.insight.90139","volume":"2","author":"J Qu","year":"2017","unstructured":"Qu, J. et al. Oxidized CaMKII promotes asthma through the activation of mast cells. JCI Insight. 2, e90139, https:\/\/doi.org\/10.1172\/jci.insight.90139 (2017).","journal-title":"JCI Insight."},{"key":"45743_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.bbamcr.2016.12.014","volume":"1864","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Huang, L. & Yue, J. Oxidative stress activates the TRPM2-Ca2+\/CaMKII-ROS signaling loop to induce cell death in cancer cells. Biochim. Biophys. Acta. 1864, 957\u2013967 (2017).","journal-title":"Biochim. Biophys. Acta."},{"key":"45743_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/01.RES.84.6.713","volume":"84","author":"B Hoch","year":"1999","unstructured":"Hoch, B., Meyer, R., Hetzer, R., Krause, E. G. & Karczewski, P. Identification and Expression of \u03b4-Isoforms of the Multifunctional Ca2+\/Calmodulin-Dependent Protein Kinase in Failing and Nonfailing Human Myocardium. Circ. Res. 84, 713\u2013721 (1999).","journal-title":"Circ. Res."},{"key":"45743_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cardiores.2005.12.003","volume":"70","author":"RJ Diaz","year":"2006","unstructured":"Diaz, R. J. & Wilson, G. J. Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc. Res. 70, 286\u201396 (2006).","journal-title":"Cardiovasc. Res."},{"key":"45743_CR27","doi-asserted-by":"publisher","first-page":"H1558","DOI":"10.1152\/ajpheart.00158.2016","volume":"310","author":"HQ Yang","year":"2016","unstructured":"Yang, H. Q. et al. Elasticity of sarcolemmal KATP channel surface expression: relevance during ischemia and ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 310, H1558\u201366 (2016).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"45743_CR28","doi-asserted-by":"publisher","first-page":"H1882","DOI":"10.1152\/ajpheart.2001.280.4.H1882","volume":"280","author":"N Sasaki","year":"2001","unstructured":"Sasaki, N., Sato, T., Marb\u00e1n, E. & O\u2019Rourke, B. ATP consumption by uncoupled mitochondria activates sarcolemmal K(ATP) channels in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 280, H1882\u20138 (2001).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"45743_CR29","first-page":"540","volume":"261","author":"I Findlay","year":"1992","unstructured":"Findlay, I. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide. J. Pharmacol. Exp. Ther. 261, 540\u20135 (1992).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"45743_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrendo.2013.166","volume":"9","author":"FM Ashcroft","year":"2013","unstructured":"Ashcroft, F. M. & Rorsman, P. K(ATP) channels and islet hormone secretion: new insights and controversies. Nat. Rev. Endocrinol. 9, 660\u20139 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"45743_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/01.RES.69.3.571","volume":"69","author":"WC Cole","year":"1991","unstructured":"Cole, W. C., McPherson, C. D. & Sontag, D. ATP-regulated K+ channels protect the myocardium against ischemia\/reperfusion damage. Circ. Res. 69, 571\u201381 (1991).","journal-title":"Circ. Res."},{"key":"45743_CR32","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1161\/01.CIR.92.8.2266","volume":"92","author":"S Shigematsu","year":"1995","unstructured":"Shigematsu, S. et al. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation. 92, 2266\u201375 (1995).","journal-title":"Circulation."},{"key":"45743_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cardiores.2003.10.025","volume":"61","author":"LB Becker","year":"2004","unstructured":"Becker, L. B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61, 461\u201370 (2004).","journal-title":"Cardiovasc. Res."},{"key":"45743_CR34","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/nm.2506","volume":"17","author":"BJ He","year":"2011","unstructured":"He, B. J. et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 17, 1610\u20138 (2011).","journal-title":"Nat. Med."},{"key":"45743_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1152\/physrev.00024.2007","volume":"88","author":"E Murphy","year":"2008","unstructured":"Murphy, E. & Steenbergen, C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88, 581\u2013609 (2008).","journal-title":"Physiol. Rev."},{"key":"45743_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.15252\/emmm.201403848","volume":"6","author":"M Weinreuter","year":"2014","unstructured":"Weinreuter, M. et al. CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia\/reperfusion injury. EMBO Mol. Med. 6, 1231\u201345 (2014).","journal-title":"EMBO Mol. Med."},{"key":"45743_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2018.02.002","volume":"116","author":"J Mustroph","year":"2018","unstructured":"Mustroph, J. et al. SR Ca2+-leak and disordered excitation-contraction coupling as the basis for arrhythmogenic and negative inotropic effects of acute ethanol exposure. J. Mol. Cell Cardiol. 116, 81\u201390 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"45743_CR38","first-page":"e005682","volume":"11","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Oxidized CaMKII (Ca2+\/Calmodulin-Dependent Protein Kinase II) Is Essential for Ventricular Arrhythmia in a Mouse Model of Duchenne Muscular Dystrophy. Circulation: Arrhythmia and Electrophysiology. 11, e005682 (2018).","journal-title":"Circulation: Arrhythmia and Electrophysiology."},{"key":"45743_CR39","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1172\/JCI38022","volume":"119","author":"H Ling","year":"2009","unstructured":"Ling, H. et al. Requirement for Ca2+\/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 119, 1230\u201340 (2009).","journal-title":"J. Clin. Invest."},{"key":"45743_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/CIRCRESAHA.112.276915","volume":"112","author":"H Ling","year":"2013","unstructured":"Ling, H. et al. Ca2+\/Calmodulin-dependent protein kinase II \u03b4 mediates myocardial ischemia\/reperfusion injury through nuclear factor-\u03baB. Circ. Res. 112, 935\u201344 (2013).","journal-title":"Circ. Res."},{"key":"45743_CR41","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1073\/pnas.0813013106","volume":"106","author":"J Backs","year":"2009","unstructured":"Backs, J. et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl. Acad. Sci. USA 106, 2342\u20137 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"45743_CR42","doi-asserted-by":"publisher","first-page":"38593","DOI":"10.1074\/jbc.M301180200","volume":"278","author":"P Rodriguez","year":"2003","unstructured":"Rodriguez, P., Bhogal, M. S. & Colyer, J. Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. J. Biol. Chem. 278, 38593\u2013600 (2003).","journal-title":"J. Biol. Chem."},{"key":"45743_CR43","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1161\/01.RES.0000125626.33738.E2","volume":"94","author":"XH Wehrens","year":"2004","unstructured":"Wehrens, X. H., Lehnart, S. E., Reiken, S. R. & Marks, A. R. Ca2+\/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 94, e61\u201370 (2004).","journal-title":"Circ. Res."},{"key":"45743_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/01.RES.75.5.854","volume":"75","author":"ME Anderson","year":"1994","unstructured":"Anderson, M. E., Braun, A. P., Schulman, H. & Premack, B. A. Multifunctional Ca2+\/calmodulin-dependent protein kinase mediates Ca(2+)-induced enhancement of the L-type Ca2+ current in rabbit ventricular myocytes. Circ. Res. 75, 854\u201361 (1994).","journal-title":"Circ. Res."},{"key":"45743_CR45","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1073\/pnas.91.20.9659","volume":"91","author":"RP Xiao","year":"1994","unstructured":"Xiao, R. P., Cheng, H., Lederer, W. J., Suzuki, T. & Lakatta, E. G. Dual regulation of Ca2+\/calmodulin-dependent kinase II activity by membrane voltage and by calcium influx. Proc. Natl. Acad. Sci. USA 91, 9659\u201363 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"45743_CR46","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI26620","volume":"116","author":"S Wagner","year":"2006","unstructured":"Wagner, S. et al. Ca2+\/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J. Clin. Invest. 116, 3127\u201338 (2006).","journal-title":"J. Clin. Invest."},{"key":"45743_CR47","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/01.CIR.89.4.1769","volume":"89","author":"Z Yao","year":"1994","unstructured":"Yao, Z. & Gross, G. J. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 89, 1769\u201375 (1994).","journal-title":"Circulation."},{"key":"45743_CR48","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1097\/00005344-199409000-00019","volume":"24","author":"GJ Grover","year":"1994","unstructured":"Grover, G. J. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J. Cardiovasc. Pharmacol. 24, S18\u201327 (1994).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"45743_CR49","first-page":"H1864","volume":"261","author":"A Mitani","year":"1991","unstructured":"Mitani, A. et al. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Am. J. Physiol. 261, H1864\u201371 (1991).","journal-title":"Am. J. Physiol."},{"key":"45743_CR50","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1006\/jmcc.1996.0335","volume":"29","author":"SD Critz","year":"1997","unstructured":"Critz, S. D., Liu, G. S., Chujo, M. & Downey, J. M. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes. J. Mol. Cell Cardiol. 29, 1123\u201330 (1997).","journal-title":"J. Mol. Cell Cardiol."},{"issue":"Suppl 2","key":"45743_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00878472","volume":"9","author":"I Cavero","year":"1995","unstructured":"Cavero, I., Djellas, Y. & Guillon, J. M. Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels. Cardiovasc. Drugs Ther. 9(Suppl 2), 245\u201355 (1995).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"45743_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cmet.2009.11.009","volume":"11","author":"AE Alekseev","year":"2010","unstructured":"Alekseev, A. E. et al. Sarcolemmal ATP-sensitive K(+) channels control energy expenditure determining body weight. Cell Metab. 11, 58\u201369 (2010).","journal-title":"Cell Metab."},{"key":"45743_CR53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","volume":"381","author":"G Heusch","year":"2013","unstructured":"Heusch, G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 381, 166\u201375 (2013).","journal-title":"Lancet."},{"key":"45743_CR54","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","volume":"120","author":"G Heusch","year":"2017","unstructured":"Heusch, G. Critical Issues for the Translation of Cardioprotection. Circ. Res. 120, 1477\u20131486 (2017).","journal-title":"Circ. Res."},{"key":"45743_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy, D. J. & Yellon, D. M. Ischaemic conditioning and reperfusion injury. Nat. Rev. Cardiol. 13, 193\u2013209 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"45743_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/phrs.2000.0669","volume":"42","author":"K Ytrehus","year":"2000","unstructured":"Ytrehus, K. The ischemic heart\u2013experimental models. Pharmacol. Res. 42, 193\u2013203 (2000).","journal-title":"Pharmacol. Res."},{"key":"45743_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1042\/CS20110562","volume":"123","author":"AF Chen","year":"2012","unstructured":"Chen, A. F. et al. Free radical biology of the cardiovascular system. Clin. Sci. (Lond). 123, 73\u201391 (2012).","journal-title":"Clin. Sci. (Lond)."},{"key":"45743_CR58","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0735-1097(01)01428-0","volume":"38","author":"HJ Ranki","year":"2001","unstructured":"Ranki, H. J., Budas, G. R., Crawford, R. M. & Jovanovi\u0107, A. Gender-specific difference in cardiac ATP-sensitive K(+) channels. J. Am. Coll. Cardiol. 38, 906\u201315 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"45743_CR59","first-page":"H2147","volume":"269","author":"LH Michael","year":"1995","unstructured":"Michael, L. H. et al. Myocardial ischemia and reperfusion: a murine model. Am. J. Physiol. 269, H2147\u201354 (1995).","journal-title":"Am. J. Physiol."},{"key":"45743_CR60","doi-asserted-by":"publisher","first-page":"H2054","DOI":"10.1152\/ajpheart.00836.2009","volume":"297","author":"S Bohl","year":"2009","unstructured":"Bohl, S. et al. Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart. Am. J. Physiol. Heart Circ. Physiol. 297, H2054\u20138 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"45743_CR61","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1073\/pnas.1202081109","volume":"109","author":"H Wei","year":"2012","unstructured":"Wei, H. et al. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc. Natl. Acad. Sci. USA 109, E841\u201350 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45743-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:57:44Z","timestamp":1671274664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45743-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45743"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45743-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.E. Anderson is a cofounder of Allosteros Therapeutics, a biotech company developing CaMKII inhibitor drugs to treat cardiovascular disease.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9291"}}